Native Albumin For Targeted Drug Delivery

We have collected information about Native Albumin For Targeted Drug Delivery for you. Follow the links to find out details on Native Albumin For Targeted Drug Delivery.


Native albumin for targeted drug delivery.

    https://www.ncbi.nlm.nih.gov/pubmed/20586704
    Covalent coupling to albumin carries drugs specifically to tumors and sites of inflammation, leading to reduced side effects as long as the native structure of albumin is unchanged. In this review, the means of coupling drugs to native albumin as well as exemplary studies for the use of albumin as drug carrier are summarized and discussed.Author: Elena Neumann, Eva Frei, Dorothee Funk, Matthias D Becker, Hans-Hermann Schrenk, Ulf Müller-Ladner, ...

(PDF) Native albumin for targeted drug delivery

    https://www.researchgate.net/publication/44850860_Native_albumin_for_targeted_drug_delivery
    Native albumin for targeted drug delivery Article · Literature Review (PDF Available) in Expert Opinion on Drug Delivery 7(8):915-25 · August 2010 with 867 Reads How we measure 'reads'

Native albumin for targeted drug delivery - ResearchGate

    https://www.researchgate.net/profile/Matthias_Becker/publication/44850860_Native_albumin_for_targeted_drug_delivery/links/0c960535d1cd2ed28c000000.pdf
    albumin-based drug delivery in a chronic inflammatory disease: rheumatoid arthritis 8. Albumin-labeled drugs for diagnostic use 9. Conclusion 10. Expert opinion Review Native albumin for targeted ...Author: Elena Neumann, Eva Frei, Dorothee Funk, Matthias D Becker, Hans-Hermann Schrenk, Ulf Müller-Ladner, ...

Native albumin for targeted drug delivery: Expert Opinion ...

    https://www.tandfonline.com/doi/abs/10.1517/17425247.2010.498474
    Covalent coupling to albumin carries drugs specifically to tumors and sites of inflammation, leading to reduced side effects as long as the native structure of albumin is unchanged. In this review, the means of coupling drugs to native albumin as well as exemplary studies for the use of albumin as drug carrier are summarized and discussed.Author: Elena Neumann, Eva Frei, Dorothee Funk, Matthias D Becker, Hans-Hermann Schrenk, Ulf Müller-Ladner, ...

(PDF) Native albumin for targeted drug delivery Matthias ...

    https://www.academia.edu/22172791/Native_albumin_for_targeted_drug_delivery
    Native albumin for targeted drug delivery

Neutrophil-Based Drug Delivery Systems

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161715/
    A promising strategy to develop novel targeted drug delivery systems is the targeting and exploitation of activated neutrophils. Here, we review a new drug delivery platform based on neutrophils. There are two types of drug delivery systems: neutrophils as carriers and neutrophil membrane-derived nanovesicles.Author: Dafeng Chu, Xinyue Dong, Xutong Shi, Canyang Zhang, Zhenjia Wang

Surface modification of polymer nanoparticles with native ...

    https://www.sciencedirect.com/science/article/pii/S0142961218305088
    Albumin is a promising surface modifier of nanoparticulate drug delivery systems. Serving as a dysopsonin, albumin can protect circulating nanoparticles (NPs) from the recognition and clearance by the mononuclear phagocytic system (MPS).Author: Hyesun Hyun, Joonyoung Park, Kiela Willis, Ji Eun Park, L. Tiffany Lyle, Wooin Lee, Yoon Yeo

Human Serum Albumin and HER2-Binding Affibody Fusion ...

    https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00265
    Aug 21, 2016 · Human epidermal growth factor receptor 2 (HER2) is a well-studied therapeutic target as well as a biomarker of breast cancer. HER2-targeting affibody (ZHER2:342) is a novel small scaffold protein with an extreme high affinity against HER2 screened by phage display. However, the small molecular weight of ZHER2:342 has limited its pharmaceutical application.Author: Daoyuan Dong, Guanjun Xia, Zhijun Li, Zhiyu Li

Impact of albumin based approaches in nanomedicine ...

    https://www.sciencedirect.com/science/article/pii/S000186861730218X
    Toxicological manifestations of many therapeutic agents were reduced through targeted delivery. Cisplatin is one such agent whose use is limited because of the dose limiting toxicities and acquired drug resistant. Folate modified albumin nanoparticles were prepared for the targeted delivery of cisplatin to reduce their adverse effects.Author: Bharat Bhushan, Vitaly Khanadeev, Boris Khlebtsov, Nikolai Khlebtsov, P. Gopinath

Searching for Native Albumin For Targeted Drug Delivery?

You can just click the links above. The data is collected for you.

Related Delivery Info